<VariationArchive VariationID="977219" VariationName="NM_000874.5(IFNAR2):c.236del (p.Asp78_Leu79insTer)" VariationType="Deletion" Accession="VCV000977219" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2021-01-26" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="965347" VariationID="977219">
      <GeneList>
        <Gene Symbol="IFNAR2" FullName="interferon alpha and beta receptor subunit 2" GeneID="3455" HGNC_ID="HGNC:5433" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>21q22.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="33229938" stop="33265664" display_start="33229938" display_stop="33265664" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="34602230" stop="34636826" display_start="34602230" display_stop="34636826" Strand="+" />
          </Location>
          <OMIM>602376</OMIM>
        </Gene>
        <Gene Symbol="IFNAR2-IL10RB" FullName="IFNAR2-IL10RB readthrough" GeneID="127882475" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>21q22.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="33229938" stop="33297221" display_start="33229938" display_stop="33297221" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000874.5(IFNAR2):c.236del (p.Asp78_Leu79insTer)</Name>
      <CanonicalSPDI>NC_000021.9:33246729:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="33246730" stop="33246730" display_start="33246730" display_stop="33246730" variantLength="1" positionVCF="33246729" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="34619035" stop="34619035" display_start="34619035" display_stop="34619035" variantLength="1" positionVCF="34619034" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.34619037del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.34619037del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.33246732del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.33246732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016003.2" sequenceAccession="NG_016003" sequenceVersion="2" change="g.21807del">
            <Expression>NG_016003.2:g.21807del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000874.5" sequenceAccession="NM_000874" sequenceVersion="5" change="c.236del">
            <Expression>NM_000874.5:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000865.2" sequenceAccession="NP_000865" sequenceVersion="2" change="p.Asp78_Leu79insTer">
            <Expression>NP_000865.2:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289125.3" sequenceAccession="NM_001289125" sequenceVersion="3" change="c.236del" MANESelect="true">
            <Expression>NM_001289125.3:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276054.1" sequenceAccession="NP_001276054" sequenceVersion="1" change="p.Asp78_Leu79insTer">
            <Expression>NP_001276054.1:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289126.2" sequenceAccession="NM_001289126" sequenceVersion="2" change="c.236del">
            <Expression>NM_001289126.2:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276055.1" sequenceAccession="NP_001276055" sequenceVersion="1" change="p.Asp78_Leu79insTer">
            <Expression>NP_001276055.1:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289128.2" sequenceAccession="NM_001289128" sequenceVersion="2" change="c.236del">
            <Expression>NM_001289128.2:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276057.1" sequenceAccession="NP_001276057" sequenceVersion="1" change="p.Asp78_Leu79insTer">
            <Expression>NP_001276057.1:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385054.1" sequenceAccession="NM_001385054" sequenceVersion="1" change="c.236del">
            <Expression>NM_001385054.1:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001371983.1" sequenceAccession="NP_001371983" sequenceVersion="1" change="p.Asp78_Leu79insTer">
            <Expression>NP_001371983.1:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385055.1" sequenceAccession="NM_001385055" sequenceVersion="1" change="c.236del">
            <Expression>NM_001385055.1:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001371984.1" sequenceAccession="NP_001371984" sequenceVersion="1" change="p.Asp78_Leu79insTer">
            <Expression>NP_001371984.1:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207584.3" sequenceAccession="NM_207584" sequenceVersion="3" change="c.236del">
            <Expression>NM_207584.3:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997467.1" sequenceAccession="NP_997467" sequenceVersion="1" change="p.Asp78_Leu79insTer">
            <Expression>NP_997467.1:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207585.3" sequenceAccession="NM_207585" sequenceVersion="3" change="c.236del">
            <Expression>NM_207585.3:c.236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997468.1" sequenceAccession="NP_997468" sequenceVersion="1" change="p.Asp78_Leu79insTer">
            <Expression>NP_997468.1:p.Asp78_Leu79insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207585.2" sequenceAccession="NM_207585" sequenceVersion="2" change="c.234delT">
            <Expression>NM_207585.2:c.234delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602376.0003" DB="OMIM" />
        <XRef Type="rs" ID="1310889473" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="variation affecting protein function">
        <XRef ID="0003" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000874.5(IFNAR2):c.236del (p.Asp78_Leu79insTer) AND not provided" Accession="RCV001879919" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000874.5(IFNAR2):c.236del (p.Asp78_Leu79insTer) AND Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection" Accession="RCV001283731" Version="3">
        <ClassifiedConditionList TraitSetID="23390">
          <ClassifiedCondition DB="MedGen" ID="C4225260">Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000874.5(IFNAR2):c.236del (p.Asp78_Leu79insTer) AND Immunodeficiency 45" Accession="RCV001780205" Version="1">
        <ClassifiedConditionList TraitSetID="23433">
          <ClassifiedCondition DB="MedGen" ID="C4225252">Immunodeficiency 45</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-11-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-15" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-01-26" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26424569</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33193576</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="23390" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34432" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 44</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection</ElementValue>
                <XRef ID="MONDO:0014715" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IMD44</ElementValue>
                <XRef Type="MIM" ID="616636" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17711" />
                <XRef ID="17711" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="431166" DB="Orphanet" />
              <XRef ID="C4225260" DB="MedGen" />
              <XRef ID="MONDO:0014715" DB="MONDO" />
              <XRef Type="MIM" ID="616636" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23433" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="34437" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency 45</ElementValue>
                <XRef ID="MONDO:0014727" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IMD45</ElementValue>
                <XRef Type="MIM" ID="616669" DB="OMIM" />
              </Symbol>
              <XRef ID="C4225252" DB="MedGen" />
              <XRef ID="MONDO:0014727" DB="MONDO" />
              <XRef Type="MIM" ID="616669" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2825700" SubmissionDate="2020-08-11" DateLastUpdated="2021-01-26" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="SUB7790511" submittedAssembly="GRCh37" title="SUB7790511" />
        <ClinVarAccession Accession="SCV001423581" DateUpdated="2021-01-26" DateCreated="2021-01-26" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics Unit, Bambino Gesù Children's Hospital" OrgID="506277" OrganizationCategory="laboratory" OrgAbbreviation="OPBG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Leu79Ter variant in IFNAR2 gene has been identified in a compound heterozygous status with a frameshift variant in a patient with high fever and lethargy after live-attenuated MMR (measles-mumps-rubella) vaccine and was absent from large population studies. Additionally, ex vivo functional studies indicate that the Leu79Ter variant causes an impairment of type I IFN-mediated responses (Passarelli, submitted). In summary, the Leu79Ter variant meets our criteria to be classified as pathogenic based upon segregation studies, absence from controls and functional evidence.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Italy</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <Description>Clinical exome, using a custom panel including 6920 genes known as associated to genetic diseases, was performed on genomic DNA by using the SeqCap EZ Enrichment Kit (Roche) according to the manufactureâ€™s protocol on a NovaSeq6000 platform (Illumina). The reads were aligned to human genome build GRCh37/UCSC hg19. The BWA Enrichment application of BaseSpace (Illumina) and the TGex software (LifeMap Sciences, Inc.) were used for the variant calling and annotating variants, respectively.</Description>
              <MethodType>case-control</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IFNAR2">
              <Name>interferon alpha and beta receptor subunit 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_207585.2:exon 5</GeneLocation>
          </Location>
          <FunctionalConsequence Value="variation affecting protein function">
            <XRef DB="Variation Ontology" ID="0003" URL="http://purl.obolibrary.org/obo/VariO_0003" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207585.2:c.234delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA431166" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7790511</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3968771" SubmissionDate="2021-11-19" DateLastUpdated="2021-11-29" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="602376.0003_IMMUNODEFICIENCY 45" title="IFNAR2, 1-BP DEL, 234T (rs1310889473)_IMMUNODEFICIENCY 45" />
        <ClinVarAccession Accession="SCV002025263" DateUpdated="2021-11-29" DateCreated="2021-11-29" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 2-year-old Italian boy with immunodeficiency-45 (IMD45; 616669), Passarelli et al. (2020) identified compound heterozygous frameshift mutations in the IFNAR2 gene: a 1-bp deletion (c.234delT, NM_207585), resulting in premature termination (Leu79Ter), and a 5-bp deletion (c.555_559delAAAAG; 602376.0004), also resulting in premature termination (Ile185MetfsTer12). The mutations, which were found by clinical exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. In vitro studies showed that patient immune cells did not respond to IFN-alpha and failed to activate the transcription of type I IFN-stimulated genes. Specific defects in NK function were thought to contribute to the development of hemophagocytic lymphohistiocytosis (HLH) after MMR vaccination observed in this patient.</Attribute>
              <Citation>
                <ID Source="PubMed">33193576</ID>
              </Citation>
              <XRef DB="OMIM" ID="616669" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IFNAR2" />
          </GeneList>
          <Name>IFNAR2, 1-BP DEL, 234T (rs1310889473)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 234T (rs1310889473)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602376.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IMMUNODEFICIENCY 45</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4259966" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13087337|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002238764" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33193576</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26424569</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33193576</ID>
          </Citation>
          <Comment>This premature translational stop signal has been observed in individual(s) with hemophagocytic lymphohistiocytosis (PMID: 33193576). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 977219). This variant is also known as c.234delT. This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Leu79*) in the IFNAR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFNAR2 are known to be pathogenic (PMID: 26424569, 33193576).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IFNAR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.34619035del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4259966" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3968771" TraitType="Disease" MappingType="Name" MappingValue="IMMUNODEFICIENCY 45" MappingRef="Preferred">
        <MedGen CUI="C4225252" Name="Immunodeficiency 45" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2825700" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA431166" MappingRef="Orphanet">
        <MedGen CUI="C4225260" Name="Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

